These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35468995)

  • 21. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
    Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic treatment of neuropathic pain.
    Attal N
    Acta Neurol Belg; 2001 Mar; 101(1):53-64. PubMed ID: 11379277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology and treatment of neuropathic pains.
    Jensen TS; Madsen CS; Finnerup NB
    Curr Opin Neurol; 2009 Oct; 22(5):467-74. PubMed ID: 19741531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA; Song DH; Oh HM; Chung ME
    Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial.
    Norrbrink C; Lundeberg T
    Clin J Pain; 2009; 25(3):177-84. PubMed ID: 19333166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic therapies of pain in patients with spinal cord injury: a systematic review.
    Asgardoon MH; Jazayeri SB; Behkar A; Dabbagh Ohadi MA; Yarmohammadi H; Ghodsi Z; Pomerani TI; Mojtahedzadeh M; Rahimi-Movaghar V
    Spinal Cord Ser Cases; 2022 Jul; 8(1):65. PubMed ID: 35788127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.
    Wong MC; Chung JW; Wong TK
    BMJ; 2007 Jul; 335(7610):87. PubMed ID: 17562735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticonvulsants or Antidepressants in Combination Pharmacotherapy for Treatment of Neuropathic Pain in Cancer Patients: A Systematic Review and Meta-analysis.
    Guan J; Tanaka S; Kawakami K
    Clin J Pain; 2016 Aug; 32(8):719-25. PubMed ID: 26491936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxycodone improves pain control and quality of life in anticonvulsant-pretreated spinal cord-injured patients with neuropathic pain.
    Barrera-Chacon JM; Mendez-Suarez JL; Jáuregui-Abrisqueta ML; Palazon R; Barbara-Bataller E; García-Obrero I
    Spinal Cord; 2011 Jan; 49(1):36-42. PubMed ID: 20820176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A focused review on the use of botulinum toxins for neuropathic pain.
    Argoff CE
    Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.
    Collins SL; Moore RA; McQuayHJ ; Wiffen P
    J Pain Symptom Manage; 2000 Dec; 20(6):449-58. PubMed ID: 11131263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis.
    Guy S; Mehta S; Leff L; Teasell R; Loh E
    Spinal Cord; 2014 Feb; 52(2):89-96. PubMed ID: 24296804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment options in postherpetic neuralgia.
    Bonezzi C; Demartini L
    Acta Neurol Scand Suppl; 1999; 173():25-35; discussion 48-52. PubMed ID: 10819089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.
    Jongen JL; Huijsman ML; Jessurun J; Ogenio K; Schipper D; Verkouteren DR; Moorman PW; van der Rijt CC; Vissers KC
    J Pain Symptom Manage; 2013 Oct; 46(4):581-590.e1. PubMed ID: 23415040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacotherapy of chronic neuropathic pain].
    Otto J; Forstenpointner J; Binder A; Baron R
    Internist (Berl); 2019 Jul; 60(7):711-723. PubMed ID: 31187164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venlafaxine for neuropathic pain in adults.
    Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatments perceived to be helpful for neuropathic pain after traumatic spinal cord injury: A multicenter cross-sectional survey study.
    Bryce TN; Tsai CY; Delgado AD; Mulroy SJ; Welch A; Cardenas DD; Taylor HB; Felix ER
    J Spinal Cord Med; 2024 May; 47(3):440-449. PubMed ID: 35993799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.